GlassScriptPhysician profile
Brian Matthew Ross
NPI 1144213786
$8,368.37
in general payments reported to CMS, 2019-2025
15 companies · $1,201 in 2025
The $1,201 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $110 · 2021: $83.14 · 2022: $821 · 2023: $3,658 · 2024: $1,907 · 2025: $1,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,889 · Travel and Lodging: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,888.66 |
| Travel and Lodging | $877.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,532.98 | 2019-2025 | Total30, Dailies Total1, Precision7 |
| Coopervision INC. | $3,163.01 | 2019-2025 | Myday Contact Lens, Cvi Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $573.22 | 2023-2025 | Infuse, Biotrue One Day, Miebo |
| Lkc Technologies, INC. | $213.02 | 2024-2025 | |
| Optos, INC. | $196.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $177.96 | 2019-2022 | |
| Abbvie INC. | $148.67 | 2022-2023 | Vuity |
| Ocular Therapeutix, INC. | $98.58 | 2025 | Dextenza |
| Oyster Point Pharma, INC. | $91.73 | 2022 | |
| Allergan, INC. | $53.13 | 2021-2022 | |
| Glaukos Corporation | $31.91 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $31.62 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $25.95 | 2025 | Xdemvy |
| Shire North American Group INC | $24.71 | 2019 | |
| Maculogix, INC. | $5.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.